08/08/2025
6:30 AM | Y-mAbs Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2025
6:18 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2025
4:11 PM | Perseus BidCo US, Inc. (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC TO-C | |
08/06/2025
4:25 PM | Y-mAbs Therapeutics (Subject)
| Form SC14D9C | |
08/06/2025
9:33 AM | Perseus BidCo US, Inc. (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC TO-C | |
08/05/2025
8:30 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2025
3:20 PM | GILL DAVID N (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:20 PM | HEALY JAMES (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:20 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:20 PM | TYAGI ASHU (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:20 PM | Hamill Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for YMAB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/05/2025
6:17 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
6:04 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
7:41 AM | Caligan Partners LP (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/13/2025
6:26 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:33 AM | Y-mAbs Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
7:14 PM | Y-mAbs Therapeutics (Filer)
| Form 10-K/A | |
03/11/2025
7:15 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:17 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:32 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
3:36 PM | Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
3:40 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
3:26 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:48 AM | Y-mAbs Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/04/2025
6:15 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
6:24 AM | Y-mAbs Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/22/2025
5:57 PM | LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:00 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:01 PM | Wilms Joris (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:03 PM | Gentilcore Douglas J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:04 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:05 PM | PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:44 PM | LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/13/2025
8:21 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:27 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:32 PM | Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
6:18 AM | Y-mAbs Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
5:55 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
1:16 PM | VANGUARD GROUP INC (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
7:51 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
7:05 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
GENIUS Act: Cancel Your Money? (Ad) A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control.
Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live. Get the free info kit with 3 strategies to sidestep digital dollar control. |
09/17/2024
4:24 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:19 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
6:06 AM | Y-mAbs Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
5:50 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
